×

Growth Reports

Growth Reports
Report Name

Biological Safety Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), Countries and Companies Report

Biological Safety Testing Market is projected to register a 10.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021827  |   No. of Pages: 197

Biologic Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), Countries and Companies Report

Biologic Therapeutics Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021826  |   No. of Pages: 193

Bioimplants Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Cardiovascular Implants, Orthopedics Implants, Spinal Implants, Dental Implants, Ophthalmic Implants, Others), By Cardiovascular Implants (Pacing Devices, -Pacemaker, -ICDs, Stents), By Orthopedics Implants (Orthobiologics, Trauma Implants, Hip Replacement, Knee Replacements), By Material (Ceramics, Polymers, Alloys, Biomaterial Metal), By Origin (Autograft, Allograft, Xenograft, Synthetic), By End-User (Hospitals, Clinics, Specialty Centers), Countries and Companies Report

Bioimplants Market is projected to register a 9.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021825  |   No. of Pages: 194

Biochemistry Analyzer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Fully Automatic, Semi-Automatic), By Modality (Bench-top, Floor standing), By Application (Clinical Diagnostics, Bioreactor Product Detection, Drug Development Applications, Others), By End-User (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Others), Countries and Companies Report

Biochemistry Analyzer Market is projected to register a 4.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021824  |   No. of Pages: 192

Bioactive Wound Dressing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Hydrocolloids, Alginate Dressing, Skin Substitutes, Antimicrobial Dressing, Others), By Application (Wounds, Burns, Ulcers, Others), Countries and Companies Report

Bioactive Wound Dressing Market is projected to register a 5.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021823  |   No. of Pages: 200

Bio-pharma Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Monoclonal antibodies, Recombinant growth factors, Vaccine, Recombinant hormones, Others), By Application (Oncology, Autoimmune disorder, Metabolic disorder, Hormonal disorder, Others), Countries and Companies Report

Bio-pharma Market is projected to register a 13.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021822  |   No. of Pages: 197

Binge-eating Disorder Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Antidepressants, Anticonvulsants, Stimulants, Others), By Distribution Channel (Offline, Online), Countries and Companies Report

Binge-eating Disorder Treatment Market is projected to register a 5.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021821  |   No. of Pages: 197

Bile Duct Cancer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (5-fluorouracil, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Hospitals, Diagnostic Laboratories, Clinics, Others), Countries and Companies Report

Bile Duct Cancer Market is projected to register a 8.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021820  |   No. of Pages: 199

BGM Device Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Device (Self-Monitoring Blood Glucose , Continuous Glucose Monitoring ), By End-User (Hospitals, Clinics, Home Usage), By Indicator (Type-1 Diabetes Population, Type-2 Diabetes Population), Countries and Companies Report

BGM Device Market is projected to register a 7.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021819  |   No. of Pages: 200

Beta-Lactam and Beta-Lactamase Inhibitors Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, Combination), By Disease (Urinary Tract Infection, Respiratory Infection, Skin Infection, Complicated Urinary Tract Infection (cUTI), Complicated Intra-Abdominal Infections (cIAI), Nosocomial Pneumonia, Blood Stream Infection, Others), By Route of Administration (Oral, Intravenous, Others), Countries and Companies Report

Beta-Lactam and Beta-Lactamase Inhibitors Market is projected to register a 2.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00021818  |   No. of Pages: 204

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us